These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 22868485

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
    Pepe P, Fraggetta F, Galia A, Grasso G, Piccolo S, Aragona F.
    Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PCA3 score vs PSA free/total accuracy in prostate cancer diagnosis at repeat saturation biopsy.
    Pepe P, Aragona F.
    Anticancer Res; 2011 Dec; 31(12):4445-9. PubMed ID: 22199313
    [Abstract] [Full Text] [Related]

  • 6. Is a single focus of low-grade prostate cancer diagnosed on saturation biopsy predictive of clinically insignificant cancer?
    Pepe P, Fraggetta F, Galia A, Candiano G, Grasso G, Aragona F.
    Urol Int; 2010 Dec; 84(4):440-4. PubMed ID: 20234121
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
    Whitman EJ, Groskopf J, Ali A, Chen Y, Blase A, Furusato B, Petrovics G, Ibrahim M, Elsamanoudi S, Cullen J, Sesterhenn IA, Brassell S, Rittenhouse H, Srivastava S, McLeod DG.
    J Urol; 2008 Nov; 180(5):1975-8; discussion 1978-9. PubMed ID: 18801539
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients.
    Goode RR, Marshall SJ, Duff M, Chevli E, Chevli KK.
    Prostate; 2013 Jan; 73(1):48-53. PubMed ID: 22585386
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is free/total PSA predictive of pathological stage and Gleason score in patients with prostate cancer and serum PSA<or=10 ng/ml?
    Pepe P, Panella P, Pietropaolo F, Pennisi M, Allegro R, Aragona F.
    Urol Int; 2006 Jan; 76(3):232-5. PubMed ID: 16601385
    [Abstract] [Full Text] [Related]

  • 13. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A.
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [Abstract] [Full Text] [Related]

  • 14. Does Ki-67 staining improve quantitative histology in preoperative prostate cancer staging?
    Pepe P, Fraggetta F, Candiano G, Aragona F.
    Arch Ital Urol Androl; 2012 Mar; 84(1):32-5. PubMed ID: 22649958
    [Abstract] [Full Text] [Related]

  • 15. Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.
    Perdonà S, Bruzzese D, Ferro M, Autorino R, Marino A, Mazzarella C, Perruolo G, Longo M, Spinelli R, Di Lorenzo G, Oliva A, De Sio M, Damiano R, Altieri V, Terracciano D.
    Prostate; 2013 Feb 15; 73(3):227-35. PubMed ID: 22821756
    [Abstract] [Full Text] [Related]

  • 16. Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.
    Ferro M, Bruzzese D, Perdonà S, Mazzarella C, Marino A, Sorrentino A, Di Carlo A, Autorino R, Di Lorenzo G, Buonerba C, Altieri V, Mariano A, Macchia V, Terracciano D.
    Clin Chim Acta; 2012 Aug 16; 413(15-16):1274-8. PubMed ID: 22542564
    [Abstract] [Full Text] [Related]

  • 17. The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.
    van Poppel H, Haese A, Graefen M, de la Taille A, Irani J, de Reijke T, Remzi M, Marberger M.
    BJU Int; 2012 Feb 16; 109(3):360-6. PubMed ID: 21883822
    [Abstract] [Full Text] [Related]

  • 18. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.
    Nakanishi H, Groskopf J, Fritsche HA, Bhadkamkar V, Blase A, Kumar SV, Davis JW, Troncoso P, Rittenhouse H, Babaian RJ.
    J Urol; 2008 May 16; 179(5):1804-9; discussion 1809-10. PubMed ID: 18353398
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer.
    Hessels D, van Gils MP, van Hooij O, Jannink SA, Witjes JA, Verhaegh GW, Schalken JA.
    Prostate; 2010 Jan 01; 70(1):10-6. PubMed ID: 19708043
    [Abstract] [Full Text] [Related]

  • 20. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A, Gallina A, Briganti A, Zanni G, Suardi N, Capitanio U, Colombo R, Bertini R, Freschi M, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2011 Apr 01; 107(8):1243-9. PubMed ID: 20883480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.